News
GlaxoSmithKline (GSK) launches QS-21 adjuvant manufacturing facility in Hamilton, Montana
Pharmaceutical manufacturer GlaxoSmithKline (GSK) held a ribbon cutting at their Hamilton facility on Thursday to celebrate the completion of a new building that will house the manufacturing of their QS-21 adjuvant.
Adjuvants are compounds that when combined with an appropriate antigen, work to elicit a stronger and more robust immune response than the antigen may be able to provide alone. That adds to the potency of vaccines such as the popular shingles vaccine Shingrex. They also provide a more lasting, durable immune response over time, which is particularly important for older adults as the immune system wanes with ageing.
MATR Supporters (view all)
Sorry, we couldn't find any posts. Please try a different search.